Related references
Note: Only part of the references are listed.Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis
Kun Liao et al.
CANCER RESEARCH (2020)
Reprogramming of Metabolism in Kidney Cancer
Hiromi Wettersten
SEMINARS IN NEPHROLOGY (2020)
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape
Akash Sabarwal et al.
CANCERS (2020)
c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer
Blanca Felipe-Abrio et al.
MOLECULAR ONCOLOGY (2019)
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2019)
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Zuzanna Tracz-Gaszewska et al.
CANCERS (2019)
Papillary Renal Cell Carcinomas Rewire Glutathione Metabolism and Are Deficient in Both Anabolic Glucose Synthesis and Oxidative Phosphorylation
Ayham Al Ahmad et al.
CANCERS (2019)
Metabolic landscape of the tumor microenvironment at single cell resolution
Zhengtao Xiao et al.
NATURE COMMUNICATIONS (2019)
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li et al.
NATURE COMMUNICATIONS (2019)
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation
Yuting Sun et al.
CELL REPORTS (2019)
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1
Samik Chakraborty et al.
ONCOGENESIS (2019)
The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
Christian R. Hoerner et al.
KIDNEY CANCER (2019)
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
Yongchang Lai et al.
CANCER CELL INTERNATIONAL (2018)
Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism
Ramachandran Rashmi et al.
CANCER RESEARCH (2018)
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin
Shuya Kandori et al.
CANCER SCIENCE (2018)
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo et al.
CELL METABOLISM (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
Heike Miess et al.
ONCOGENE (2018)
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine
Mark P. S. Dunphy et al.
RADIOLOGY (2018)
Metabolomics and Metabolic Reprogramming in Kidney Cancer
Robert H. Weiss
SEMINARS IN NEPHROLOGY (2018)
Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Luis Eduardo Zucca et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)
Christopher J. Ricketts et al.
CELL REPORTS (2018)
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D. Courtney et al.
CELL METABOLISM (2018)
Urine Tricarboxylic Acid Cycle Metabolites Predict Progressive Chronic Kidney Disease in Type 2 Diabetes
Jian-Jun Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
CXCL12 and MYC control energy metabolism to support adaptive responses after kidney injury
Toma A. Yakulov et al.
NATURE COMMUNICATIONS (2018)
Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions
W. Kimryn Rathmell et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis
Christos Chinopoulos et al.
ASN NEURO (2018)
Kidney outer medulla mitochondria are more efficient compared with cortex mitochondria as a strategy to sustain ATP production in a suboptimal environment
Tomas A. Schiffer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Metabolic reprogramming in clear cell renal cell carcinoma
Hiromi I. Wettersten et al.
NATURE REVIEWS NEPHROLOGY (2017)
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Weinan Du et al.
NATURE COMMUNICATIONS (2017)
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3
Qiao Zhang et al.
ONCOTARGET (2017)
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation
Cristina Bianchi et al.
ONCOTARGET (2017)
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
Murugabaskar Balan et al.
SCIENTIFIC REPORTS (2017)
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
Amrita M. Nargund et al.
CELL REPORTS (2017)
Therapeutic Effect of Sodium Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Renal Cell Carcinoma
Haoyu Kuang et al.
MEDICAL SCIENCE MONITOR (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients
Stein Hallan et al.
EBIOMEDICINE (2017)
FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
Timothy S. Heuer et al.
EBIOMEDICINE (2017)
The Warburg Effect and the Hallmarks of Cancer
Laurent Schwartz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging
Omran Abu Aboud et al.
CANCER RESEARCH (2017)
iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding
Wenjie Ge et al.
CANCER CELL (2017)
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
Noboru Nakaigawa et al.
BMC CANCER (2017)
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Zhaoyong Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
COX-2 Expression in Renal Cell Carcinoma and Correlations with Tumor Grade, Stage and Patient Prognosis
Hedieh Moradi Tabriz et al.
Asian Pacific Journal of Cancer Prevention (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α
Desiree Schonenberger et al.
CANCER RESEARCH (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
Laurence Albiges et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas
Scott M. Haake et al.
MOLECULAR CANCER RESEARCH (2016)
The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
Zheqiong Tan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Evan C. Lien et al.
NATURE CELL BIOLOGY (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genetic predisposition to kidney cancer
Laura S. Schmidt et al.
SEMINARS IN ONCOLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
Caroline Jochems et al.
ONCOTARGET (2016)
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Josephine F. Trott et al.
ONCOTARGET (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
Basudev Chowdhury et al.
PLOS ONE (2016)
Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC)
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
Novel drugs that target the metabolic reprogramming in renal cell cancer
Johannes C. van der Mijn et al.
CANCER & METABOLISM (2016)
Impact of MYC in regulation of tumor cell metabolism
Therese Wahlstrom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
Zachary T. Schug et al.
CANCER CELL (2015)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth
Xiaojun Zha et al.
CANCER LETTERS (2015)
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
Hiromi I. Wettersten et al.
CANCER RESEARCH (2015)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
Expression of lactate/H+ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemicat and The Cancer Genome Atlas data analyses
Younghye Kim et al.
HUMAN PATHOLOGY (2015)
Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression
Murugabaskar Balan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Shiran Rabinovich et al.
NATURE (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Emelyn H. Shroff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism
Yan Sun et al.
TUMOR BIOLOGY (2015)
HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma
Bo Qiu et al.
CANCER DISCOVERY (2015)
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
Giuseppe Lucarelli et al.
ONCOTARGET (2015)
Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma
Edward L. LaGory et al.
CELL REPORTS (2015)
Renal Cell Carcinoma in Tuberous Sclerosis Complex
Ping Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
Jennifer A. McAlpine et al.
BMC CANCER (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer
Carole Sourbier et al.
CANCER CELL (2014)
Acetate Dependence of Tumors
Sarah A. Comerford et al.
CELL (2014)
Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
Martin H. Voss et al.
CLINICAL CANCER RESEARCH (2014)
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
Xuehui Hong et al.
GUT (2014)
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells
Federica Morani et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport
Chendong Yang et al.
MOLECULAR CELL (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
L-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Eun-Hee Shim et al.
CANCER DISCOVERY (2014)
Regulation of the pentose phosphate pathway in cancer
Peng Jiang et al.
PROTEIN & CELL (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Hereditary leiomyomatosis and renal cell carcinoma
Laura S. Schmidt et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
Paulo A. Gameiro et al.
CELL METABOLISM (2013)
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein et al.
CLINICAL CANCER RESEARCH (2013)
Autotaxin-Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma
Shih-Chi Su et al.
CLINICAL CANCER RESEARCH (2013)
Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
Veronique Nogueira et al.
CLINICAL CANCER RESEARCH (2013)
Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma
Christina A. von Roemeling et al.
CLINICAL CANCER RESEARCH (2013)
DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
Pascale Fisel et al.
CLINICAL CANCER RESEARCH (2013)
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
J.M. Mates et al.
CURRENT MOLECULAR MEDICINE (2013)
IDH1 and IDH2 Mutations in Gliomas
Adam L. Cohen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Aerobic glycolysis: a novel target in kidney cancer
Brian Shuch et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
The VHL/HIF axis in clear cell renal carcinoma
Chuan Shen et al.
SEMINARS IN CANCER BIOLOGY (2013)
The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond
Marcus Conrad et al.
AMINO ACIDS (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Role of monocarboxylate transporters in human cancers: state of the art
Celine Pinheiro et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Andrew R. Mullen et al.
NATURE (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Puspa R. Pandey et al.
Recent Patents on Anti-Cancer Drug Discovery (2012)
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Jie Zheng
ONCOLOGY LETTERS (2012)
A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer
Youfeng Yang et al.
CANCER GENETICS (2012)
Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and cryptic targets of transcription factors
Aikseng Ooi et al.
CHINESE JOURNAL OF CANCER (2012)
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
L. E. Moore et al.
ONCOGENESIS (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway
Irina Daurkin et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8+ T-cell infiltration in the tumor
Katrin Singer et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Prostaglandin E2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway
Juanjuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC
Toshinari Yamasaki et al.
NATURE REVIEWS UROLOGY (2011)
Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion
Sunil Sudarshan et al.
PLOS ONE (2011)
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
Katherine A. Janeway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Glutamine Synthetase Immunostaining Correlates with Pathologic Features of Hepatocellular Carcinoma and Better Survival after Radiofrequency Thermal Ablation
Barbara Dal Bello et al.
CLINICAL CANCER RESEARCH (2010)
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation
Nukhet Aykin-Burns et al.
BIOCHEMICAL JOURNAL (2009)
Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells
Melissa A. Fath et al.
CANCER BIOLOGY & THERAPY (2009)
MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
Sai-Wen Tang et al.
CANCER LETTERS (2009)
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
Linda J. Nicholson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Grade-dependent Proteomics Characterization of Kidney Cancer
Bertrand Perroud et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
Deliang Guo et al.
SCIENCE SIGNALING (2009)
The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency
Jean-Pierre Bayley et al.
BMC MEDICAL GENETICS (2008)
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
Sudha Mannava et al.
CELL CYCLE (2008)
Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer
Sigrun Langbein et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Tawnya L. Bowles et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Alfredo Toschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma
Akio Horiguchi et al.
JOURNAL OF UROLOGY (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PTEN-deficient cancers depend on PIK3CB
Susan Wee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome
Maria J. Merino et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Expression of GLUT1 in primary renal tumors - Morphologic and biologic implications
Ayhan Ozcan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
Elaine D. MacKenzie et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Cheol-Yong Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma
M. Ugur Mungan et al.
EUROPEAN UROLOGY (2006)
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells
Javier A. Menendez et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake
AL Edinger et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma
H Simonnet et al.
CARCINOGENESIS (2002)
Share Paper
